Trypanosoma caninum, a New Parasite Described in Dogs in Brazil: Aspects of Natural Infection
read more
Citations
Trypanosoma caninum n sp (Protozoa Kinetoplastida) isolated from intact skin of a domestic dog (
Efficacy of Recombinase Polymerase Amplification to Diagnose Trypanosoma cruzi Infection in Dogs with Cardiac Alterations from an Endemic Area of Mexico.
Trypanosomatids in Small Mammals of an Agroecosystem in Central Brazil: Another Piece in the Puzzle of Parasite Transmission in an Anthropogenic Landscape.
Trypanosoma amblyommi sp. nov. (Protozoa: Kinetoplastida) isolated from Amblyomma brasiliense (Acari: Ixodidae) ticks in Rio de Janeiro, Brazil.
Isolation and partial characterisation of a novel Trypanosoma from the tick Ixodes ricinus
References
Use of molecular probes and PCR for detection and typing of Leishmania - a mini-review
PCR identification of Leishmania in diagnosis and control of canine Leishmaniasis.
Molecular diagnosis of canine visceral leishmaniasis: identification of Leishmania species by PCR-RFLP and quantification of parasite DNA by real-time PCR.
Trypanosomes in a declining species of threatened Australian marsupial, the brush-tailed bettong Bettongia penicillata (Marsupialia: Potoroidae)
Related Papers (5)
Frequently Asked Questions (10)
Q2. What is the reason for the lack of knowledge about the biological cycle of T. caninum?
The lack of knowledge about the biological cycleof T. caninum restricts the choice of biological samples to beanalyzed and of more appropriate tools for its diagnosis.
Q3. What was the PCR assay performed with the skin fragments of the 14 dogs?
The PCR assay (18S rDNA) performed with skin fragments ofthe 14 dogs, collected at the moment of the initial diagnosis,showed positive results with amplification products similar to T.caninum in 12 cases, and 2 animals showed negative results.
Q4. What tests were used to detect anti-Leishmania sp.?
Anti-T. caninum IgG antibodies were researched using in-house tests (IFAT and ELISA) with homologue antigens following protocols already standardized by their group (Alves et al., 2012).
Q5. What tests were used to detect anti-Leishmania IgG antibodies?
For the tests to detect antiLeishmania IgG antibodies, IFAT (IFI-leishmaniose visceral canina), ELISA (EIE-leishmaniose visceral canina), and the rapid immunochromatographic test (DPPt) kits were used.
Q6. What is the significance of the results?
The results obtained herein, associated to previousobservations, suggest that T. caninum infection can be asymp-tomatic, without specific clinical signs, and occurs with lowparasitemia, making its detection difficult by the methods used upto the moment.
Q7. What was the purpose of the study?
The animals were followed up at intervals of 3, 6, and 12 mo after the initial diagnosis in order to evaluate the clinical evolution of the infection by T. caninum and investigate the parasite or the DNA in different biological samples by parasitological and molecular tools.
Q8. What can be the effect of the test and the biological sample?
In fact,both the test and the biological sample analyzed can have animpact on the sensitivity and specificity of the diagnostic test and,consequently, on the infection prevalence rates.
Q9. What was the amplification of Leishmania DNA in the bone marrow sample?
Of the skin fragments collected from 8 dogs after 3 mo, 4 werePCR positive for T. caninum (nos. 527, 798, 799, and 808),whereas the research of Leishmania DNA was negative in all 8cases.
Q10. What was the procedure for obtaining the blood?
(2) Bone marrow: about 0.5–1.0 ml were collected from the sternum and placed into a tube containing EDTA and processed in the same way as the blood.